Page last updated: 2024-11-05

thalidomide and Coma

thalidomide has been researched along with Coma in 3 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.

Research Excerpts

ExcerptRelevanceReference
"Childhood tuberculous meningitis is associated with serious long-term sequelae, including mental retardation, behavior disturbances, and motor handicap."2.71Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. ( Hanekom, WA; Haslett, PA; Kaplan, G; Schoeman, JF; Springer, P; Swanevelder, S; van Rensburg, AJ, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tannemaat, MR1
Vries, EP1
Molendijk, WJ1
Haan, J1
do Prado, AD1
Schmoeller, D1
Bisi, MC1
Piovesan, DM1
Dias, FS1
Staub, HL1
Schoeman, JF1
Springer, P1
van Rensburg, AJ1
Swanevelder, S1
Hanekom, WA1
Haslett, PA1
Kaplan, G1

Trials

1 trial available for thalidomide and Coma

ArticleYear
Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study.
    Journal of child neurology, 2004, Volume: 19, Issue:4

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antitubercular Agents; Chemotherapy, Adjuvant; Ch

2004

Other Studies

2 other studies available for thalidomide and Coma

ArticleYear
Fatal ischemic stroke in a patient receiving lenalidomide for multiple myeloma.
    Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:6

    Topics: Anticoagulants; Antineoplastic Agents; Coma; Fatal Outcome; Female; Heparin, Low-Molecular-Weight; H

2011
Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
    International journal of dermatology, 2012, Volume: 51, Issue:8

    Topics: Brain Diseases; Coma; Humans; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Myeloablative

2012